In the present study, we have produced recombinant paraflagellar rod proteins (PFR) and report their use for successful vaccination of mice against Trypanosoma cruzi. This protection is associated with a highly polarized type 1 cytokine production profile. Additionally, we have analyzed the gene sequence encoding PFR-2 to determine the degree of conservation among seven highly diverse strains of T. cruzi, and found it to be highly conserved. The results presented here indicate that the PFR antigens are highly conserved, and immunization with rPFR-1, PFR-2, or an equimolar mix of the PFR-1, -2, and -3 proteins provides protective immunity against Trypanosoma cruzi.
Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection.
Keith A. Luhrs,D. Fouts,J. Manning
Published 2003 in Vaccine
ABSTRACT
PUBLICATION RECORD
- Publication year
2003
- Venue
Vaccine
- Publication date
2003-06-20
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-41 of 41 references · Page 1 of 1
CITED BY
Showing 1-41 of 41 citing papers · Page 1 of 1